Infl ammatory bowel diseases (IBDs) comprise a spectrum of immune-mediated conditions in which the target organ is the intestine. IBD is divided into two primary forms, Crohn ' s disease and ulcerative colitis ( 1 ) . Although the etiology remains unknown, increasing evidence suggests that IBD is the result of a dysregulated mucosal infl ammatory response ( 2 ) . TNF is a particularly important contributor to intestinal infl ammation, and blockade of TNF with anti-TNF antibodies is an eff ective treatment for a subset of Crohn ' s disease patients ( 3 ) . Several lines of evidence point to the TNF-related cytokine LIGHT (homologous to lymphotoxin, shows inducible expression, and competes with HSV glycoprotein D for herpes virus entry mediator [HVEM], a receptor expressed by T lymphocytes) as another important mediator of mucosal infl ammation and IBD pathogenesis ( 4 -6 ) . Activated T cells and immature DCs ex-press LIGHT, and it has been described as a proinfl ammatory cytokine and a potent T cell co-stimulatory molecule ( 7 -10 ) . Mature Th1type CD4 + T cells and mucosal T cells isolated from patients with IBD express high levels of LIGHT ( 4 ) . Furthermore, transgenic mice with T cells constitutively expressing LIGHT developed spontaneous multi-organ infl ammation that included the intestine ( 11, 12 ) , and intestinal infl ammation could be induced by transfer of LIGHT transgenic T cells ( 13 ) .
LIGHT signals via two members of the TNF receptor super family, the lymphotoxin ␤ receptor, predominantly expressed by myeloid lineage, stromal, and epithelial cells ( 14 -17 ) , and the HVEM, broadly expressed by hematopoietic cells as well as by some somatic cells ( 18 -21 ) . LIGHT-mediated IBD pathogenesis in mice has been attributed to its interaction with both of these receptors ( 6 ) . Whereas the interaction of LIGHT with lymphotoxin ␤ receptor is thought to induce transformations in the adoptive transfer of CD4 + CD45RB high naive T cells, depleted of CD25 + regulatory T cells, into syngeneic Rag Ϫ / Ϫ mice. This leads to a progressive disease, with weight loss and colitis appearing 5 -10 wk after the transfer ( 33 ) . To evaluate if the expression of HVEM in T cells is required for colitis induction, we transferred CD4 + CD45RB high T cells isolated from Hvem Ϫ / Ϫ or WT mice into Rag Ϫ / Ϫ recipients. As expected, WT donor CD4 + CD45RB high T cells induced a gradual weight loss in Rag Ϫ / Ϫ recipients that correlated with disease progression, as did the transfer of Hvem Ϫ / Ϫ CD4 + CD45RB high T cells ( Fig. 1 A ) . Although at early time points after the transfer weight loss in the Rag Ϫ / Ϫ recipient mice of Hvem Ϫ / Ϫ T cells was slightly less pronounced, the recipients the gut mucosa that alter the normal microenvironment of the intestine, its binding with HVEM expressed by T cells promotes T cell activation and the T cell expansion required for the full development of disease ( 6 ) . In other contexts, engagement of HVEM by LIGHT delivers co-stimulatory signals leading to T cell activation ( 8, 9, 18, 22 ) and enhanced T cell -mediated immunity ( 11, 12, 19, 23, 24 ) . Furthermore, it has been described that engagement of HVEM by LIGHT induced activation of human mucosal T cells and increased IFN-␥ release ( 4 ) . Therefore, it appears that HVEM may contribute to IBD pathogenesis by promoting T cell activation and Th1 responses ( 4, 6 ) .
It has been recently discovered, however, that HVEM can also deliver inhibitory signals to T cells ( 25, 26 ) . These inhibitory signals involve a receptor that binds HVEM, a member of the Ig super family called B and T lymphocyte attenuator (BTLA) ( 25 ) . Once engaged by HVEM, the ITIM motifs in the cytoplasmic tail of BTLA become tyrosine phosphorylated, allowing the recruitment of the phosphatases SHP-1 and SHP-2 ( 27, 28 ) . Recent studies have shown that HVEM-as well as BTLA-defi cient T cells are hyperresponsive to TCR-induced stimulation in vitro ( 26 -28 ) . Additionally, both HVEM-and BTLA-defi cient mice presented a higher susceptibility to experimental autoimmune encephalomyelitis ( 26, 28 ) , whereas the loss of BTLA dramatically accelerated partially MHC-mismatched cardiac allograft rejection ( 29 ) and prolonged airway inflammation ( 30 ) . Furthermore, the BTLA -HVEM interaction limited T cell activity in vivo, negatively regulating the homeostatic expansion of a subset of CD8 + memory T cells ( 31 ) . Despite its generally inhibitory role, BTLA has recently been reported to play a role in promoting the survival of T cells activated during a mouse model of graft versus host disease (GVHD) ( 32 ) .
Therefore, whereas some evidence indicates that HVEM is the co-stimulatory receptor responsible for LIGHT-mediated T cell activation, other data demonstrate that HVEM can be a negative regulator of T cell responses by triggering BTLA-derived inhibitory signals. The actual contribution of HVEM to T cell -mediated immune responses, and to the pathogenesis of T cell -mediated infl ammatory conditions such as IBD, remains to be determined. Moreover, most of the studies that investigate the role of HVEM binding to its ligands have emphasized the expression of one or more of these molecules by B and T lymphocytes, and their roles in directly regulating lymphocyte responses. In this study, we investigated the role of HVEM and its binding partners in the development of colitis induced by the transfer of CD4 + CD45RB high T cells into Rag Ϫ / Ϫ mice, and the possible function of HVEM in cells of the innate immune system that are present in the Rag Ϫ / Ϫ hosts.
RESULTS

The role of HVEM expression by T cells in colitis induction
To investigate the participation of HVEM in colitis pathogenesis, we used an experimental mouse model initiated by unquestionably became ill, eventually all the transferred Rag Ϫ / Ϫ recipients showed an equivalent weight loss ( Fig. 1 A ) , and the overall diff erence between Hvem Ϫ / Ϫ and WT donor T cells did not reach statistical signifi cance. Microscopic analysis of hematoxylin and eosin (H & E)-stained tissue sections obtained from the large intestine of transferred mice revealed severe infl ammation in all of the recipients. However, mice transferred with Hvem Ϫ / Ϫ T cells had lower mononuclear cell infi ltrates in the proximal and distal colon. In addition, these recipients had a higher number of goblet cells in the distal colon, indicating that infl ammation in these animals was milder ( Fig. 1 B ) . Scoring of sections obtained from the recipients transferred with Hvem Ϫ / Ϫ T cells showed a lower average histological score than in the animals that received WT T cells ( Fig. 1 C ) . Overall, these results suggest that HVEM expression on donor T cells contributed to a limited extent to increasing intestinal infl ammation; however, HVEM expression in T cells was not absolutely required for colitis development. ter transfer, intraepithelial CD4 + TCR-␤ + cell numbers in Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice were 10-fold higher (P < 0.005) ( Fig.  3 B ) . Accordingly, the number of CD4 + TCR-␤ + lamina propria lymphocytes (LPLs) was also signifi cantly higher in Hvem Ϫ / Ϫ Rag Ϫ / Ϫ recipients at 2 wk ( Fig. 3 B ) . Collectively, these results demonstrate that the absence of HVEM in the Rag Ϫ / Ϫ mice led to a more rapid accumulation of transferred T cells in the MLNs and large intestine.
Increased T cell cytokine production in Hvem ؊ / ؊ Rag ؊ / ؊ recipients To further characterize the colitis acceleration observed in Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice, we investigated the profile of cytokines produced in the large intestine of the recipient animals. 2 wk after transfer, total mRNA was purifi ed from the colon and subjected to RT-PCR analysis for several cytokines. RT-PCR revealed the presence of TNF and IFN-␥ mRNAs, and lower levels of IL-17 mRNA ( Fig. 3 C ) . Notably, the amount of mRNA for these cytokines, and in particular for TNF, was considerably higher in samples isolated from Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice ( Fig. 3 C ) . The higher level of proinfl ammatory cytokines in the intestine of Hvem Ϫ / Ϫ Rag Ϫ / Ϫ animals correlated with the rapid and severe intestinal infl ammation observed. It should be noted that increased mRNA for TGF-␤ and IL-10 in the Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice was also observed when compared with Rag Ϫ / Ϫ recipients. The increased presence of these antiinfl ammatory cytokine mRNAs in the Hvem Ϫ / Ϫ Rag Ϫ / Ϫ recipients could refl ect a compensatory regulatory mechanism in the face of infl ammation, although the amount of IL-10 mRNA was very low in all the samples ( Fig. 3 D ) . The amount of mRNA for IL-12 family cytokines in the colon was not very great, but in accord with the higher levels of IFN-␥ mRNA observed in Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice, we also detected an increase in IL-12 mRNA in the colon of these animals ( Fig. 3 E ) . The level of mRNA for IL-23, however, was equivalent in both Rag Ϫ / Ϫ and Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice ( Fig. 3 E ) .
To determine if the transferred T cells had the capacity to produce proinfl ammatory cytokines in the colon of the Hvem Ϫ / Ϫ Rag Ϫ / Ϫ recipient mice, we evaluated cytokine production by donor-derived LPLs restimulated in vitro. LPLs were purifi ed from the large intestine of Rag Ϫ / Ϫ or Hvem Ϫ / Ϫ Rag Ϫ / Ϫ recipient mice, stimulated with PMA, and ionomycin, and 48 h later cytokines were determined by ELISA. The amounts of IFN-␥ , TNF, and IL-2 in the culture supernatants of cells obtained from Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice were considerably higher than those secreted by cells isolated from Rag Ϫ / Ϫ recipients ( Fig. 3 F ) . Rather than an increased capacity to produce cytokines, the higher amounts of cytokines in the cultures of cells isolated from Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice could have been due to the increased number of T cells in the LPL preparations. Indeed, the percentage of CD4 + TCR-␤ + within the LPL suspension isolated from Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice was about twofold higher than that observed in Rag Ϫ / Ϫ animals (not depicted). The increment in cytokines in the isolated LPLs from Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice was increased more than twofold, severe intestinal infl ammation. Examination of H & E-stained sections obtained from Hvem Ϫ / Ϫ Rag Ϫ / Ϫ recipients revealed prominent epithelial cell hyperplasia, absence of goblet cells, and a massive infi ltration of mononuclear cells in the colons of these animals ( Fig. 2 B ) . Histological analysis performed on samples isolated from large intestine of these recipients 2 wk after transfer had an average pathology score of 8.8 ± 2.2 out of a possible of 14 ( Fig. 2 C ) . Samples from Rag Ϫ / Ϫ recipients at the same early time after transfer showed almost intact epithelial crypts with absence of epithelial cell hyperplasia and only few mononuclear cell infi ltrates ( Fig. 2 B ) . The average score for samples obtained from the transferred Rag Ϫ / Ϫ mice at this time was only 0.8 ± 1.0 ( Fig. 2 C ) .
We transferred Hvem Ϫ / Ϫ donor T cells into Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice to analyze the situation in which HVEM is entirely missing. Interestingly, induced colitis and wasting disease in the completely HVEM-defi cient situation were still accelerated compared with transfers to Rag Ϫ / Ϫ animals. Weight loss in Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice transferred with HVEM-defi cient T cells was equally accelerated compared with the same recipients transferred with WT T cells ( Fig. 2 D ) . Histological scores in these recipients completely lacking HVEM were also equivalent to those observed in Hvem Ϫ / Ϫ Rag Ϫ / Ϫ animals transferred with WT T cells ( Fig. 2 E ) . Overall, these results demonstrate that the absence of HVEM expression in Rag Ϫ / Ϫ host cells led to a dramatic acceleration of colitis, and they show that this dramatic eff ect was dominant over any deceleration of disease caused by the absence of HVEM expression by donor T cells.
Rapid accumulation of T cells in the large intestine of Hvem
To characterize the colitis acceleration observed in Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice, we investigated the fate of the transferred T cells. We determined the number of CD4 + T lymphocytes in the spleens and mesenteric lymph nodes (MLNs) of transferred mice, two sites where T cells expand dramatically after transfer to immune-defi cient hosts ( 34, 35 ) . 1 wk after transfer, the number of CD4 + T cells in the MLNs of Hvem Ϫ / Ϫ Rag Ϫ / Ϫ animals was approximately threefold higher than in Rag Ϫ / Ϫ mice ( Fig. 3 A ) . This diff erence was highly signifi cant (P = 0.005). The number of T cells in the spleens of Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice was also slightly higher than in Rag Ϫ / Ϫ recipients, although not statistically signifi cant ( Fig. 3 A ) . Elevated numbers of T cells in the MLNs of Hvem Ϫ / Ϫ Rag Ϫ / Ϫ animals were only observed at early time points after the transfer, and by 2 wk after transfer, the number of CD4 + TCR-␤ + lymphocytes in the MLNs was essentially equivalent in both recipients ( Fig. 3 B ) . To investigate if the early accumulation of transferred T cells in inductive sites such as MLNs in the Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice also aff ected the target organ, we assessed the accumulation of CD4 + TCR-␤ + T cells in the large intestine of the recipients. As early as 7 d after transfer, T lymphocytes were detectable in the large intestine. At this time, the average number of CD4 + TCR-␤ + cells infi ltrating the epithelium of the Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice was 2.3-fold higher than in Rag Ϫ / Ϫ mice ( Fig. 3 A ) . However, by 2 wk af-JEM VOL. 205, June 9, 2008 ARTICLE 1467 CD11c + cells freshly isolated from the MLNs of the two types of mice expressed equivalent levels of the co-stimulatory molecules CD86 and CD80, suggesting that the DC maturation state was not greatly aff ected by the absence of HVEM ( Fig. S1 A) . To determine if the threshold for stimulation for DCs is altered in the absence of HVEM, CD11c + cells from MLNs were stimulated with LPS. Upon stimulation, both WT and Hvem Ϫ / Ϫ DCs expressed similar levels of CD40 and CD86 ( Fig. S1 B) . Moreover, after LPS stimulation, the percentage of WT and Hvem Ϫ / Ϫ MLN DCs expressing IL-12 was essentially equivalent ( Fig. S1 B) . Collectively, these results demonstrate that the absence of HVEM in DCs did not signifi cantly aff ect their percentage, maturation state, or their capacity to secrete cytokines. For priming naive CD4 + T cells, freshly isolated DCs from the MLNs of Hvem Ϫ / Ϫ mice were slightly more eff ective than their WT counterparts (proliferation indices of 2.6 and 2.1, respectively), although splenic DCs from these mice were not diff erent from WT mice ( Fig. S1 C) . Likewise MLN DCs from mice defi cient for the HVEM ligand BTLA did not prime more however, suggesting that increased proinfl ammatory cytokines in the LPLs of these recipients could be due to a combination of increased cell number and increased eff ectors. Collectively, these fi ndings suggest that the presence of increased CD4 + T cells secreting high amounts of proinfl ammatory cytokines in the intestine of Hvem Ϫ / Ϫ Rag Ϫ / Ϫ recipients contributed to the more rapid development of colitis.
DCs were not greatly affected in Hvem ؊ / ؊ mice Previous reports have suggested a role for HVEM in DC maturation and cytokine production ( 36, 37 ) , and therefore the absence of HVEM expression on DCs in the Rag Ϫ / Ϫ recipients might cause an abnormal development and/or function of these cells. In WT or Hvem Ϫ / Ϫ mice, however, the percentage of DCs in the spleens and MLNs was essentially equivalent, and the two major subsets of DCs, those expressing high levels of CD11c and CD8 ␣ , and those expressing CD11b, were similarly represented in the MLNs of WT and Hvem Ϫ / Ϫ animals ( Fig. S1 A, available at http://www.jem .org/cgi/content/full/jem.20071160/DC1, and not depicted). given Fig. 4 A ) . To verify that the chimeric mice were properly reconstituted, 8 wk after BM transplantation HVEM expression in peripheral blood cells from these animals was monitored. As expected, blood cells isolated from Hvem Ϫ / Ϫ Rag Ϫ / Ϫ → Rag Ϫ / Ϫ mice expressing the hematopoietic lineage marker CD45 did not have detectable surface HVEM, indicating reconstitution by the Hvem Ϫ / Ϫ donor BM cells ( Fig. 4 B ) . In contrast, in Rag Ϫ / Ϫ → Hvem Ϫ / Ϫ Rag Ϫ / Ϫ chimeric mice the vast majority of the hematopoietic cells expressed intermediate or high levels of HVEM, indicating that they derived from the Hvem +/+ donors ( Fig. 4 B ) . A similar degree of reconstitution was observed when organs containing immune cells from the chimeras were analyzed (not depicted).
Surprisingly, the transfer of CD4 + CD45RB high T cells into Rag Ϫ / Ϫ → Hvem Ϫ / Ϫ Rag Ϫ / Ϫ chimeric recipients induced a eff ectively ( Fig. S1 C) . In summary, HVEM defi ciency did not grossly alter DCs, and the small increase in proliferation of naive T cells stimulated with Hvem Ϫ / Ϫ DCs from MLNs is unlikely to account by itself for the accelerated T cell expansion and colitis pathogenesis in Hvem Ϫ / Ϫ recipients.
HVEM expression in radioresistant cells is required to prevent colitis acceleration
Because there was not an obvious APC defect in the Hvem Ϫ / Ϫ mice, to begin to identify the critical cell type(s) that must express HVEM, we analyzed chimeric Rag Ϫ / Ϫ recipient mice that expressed HVEM only in irradiation-resistant cells, or only in cells derived from BM progenitors. To construct the chimeras, after lethal irradiation,
and reciprocal chimeras were constructed in Rag Ϫ / Ϫ mice Rag Ϫ / Ϫ animals and accelerated development of disease. We therefore performed transfer experiments using Light Ϫ / Ϫ donor T cells. The results showed similar weight loss in Rag Ϫ / Ϫ mice transferred with either Light Ϫ / Ϫ or WT CD4 + CD45RB high T cells ( Fig. 5 A ) . However, histological analysis performed in samples obtained from the large intestine of Rag Ϫ / Ϫ recipients 12 wk after the transfer revealed lower levels of infl ammation in animals transferred with Light Ϫ / Ϫ T cells ( Fig. 5 B ) . This is consistent with other data indicating that LIGHT is a co-stimulatory molecule for T lymphocytes. Because the outcome after transfer of Light Ϫ / Ϫ T cells was opposite to the results after transfer to Hvem Ϫ / Ϫ Rag Ϫ / Ϫ recipients, we conclude that the accelerating eff ects of host HVEM defi ciency were not due to the absence of interactions with LIGHT expressed by the donor T cells.
Importantly, the transfer of Light Ϫ / Ϫ CD4 + CD45RB high T cells into Hvem Ϫ / Ϫ Rag Ϫ / Ϫ recipients induced a dramatic acceleration of weight loss ( Fig. 5 C ) and colitis progression assessed by the presence of diarrhea and other clinical signs. The disease acceleration was similar to that observed in Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice transferred with WT T cells. Furthermore, the histological scores obtained with samples isolated from these Hvem Ϫ / Ϫ Rag Ϫ / Ϫ animals 2 wk after the transfer showed equivalent levels of intestinal infl ammation, regardless of the presence of LIGHT expression by the donor T cells ( Fig. 5 D ) . rapidly developing disease ( Fig. 4 C ) . Similar to the intact Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice, Rag Ϫ / Ϫ → Hvem Ϫ / Ϫ Rag Ϫ / Ϫ recipients lost > 20% of their initial weight by 2 wk after T cell transfer. Conversely, Hvem Ϫ / Ϫ Rag Ϫ / Ϫ → Rag Ϫ / Ϫ chimeric recipients that received CD4 + CD45RB high T lymphocytes did not lose body weight in the same period of time ( Fig. 4 C ) . Consistent with the diff erence in weight loss, histological scoring performed in large intestine samples collected from the transferred chimeric recipients revealed a more severe infl ammation and tissue damage in Fig. 4 D ) . These results indicate that HVEM prevents colitis acceleration principally when expressed by radioresistant cells in the Rag Ϫ / Ϫ hosts.
A radiation-resistant cell that might prevent accelerated infl ammation through HVEM expression is the intestinal epithelial cell (IEC). In fact, human epithelial carcinoma cell lines (not depicted) and freshly isolated mouse colonic epithelial cells express HVEM ( Fig. S2 A, available at http:// www.jem.org/cgi/content/full/jem.20071160/DC1). A feature of IBD, in particular Crohn ' s disease, is increased intestinal permeability arising from a defect in the intestinal epithelium. Permeability to D-[1-14 C]-mannitol therefore was measured across tissues from proximal and distal large intestine, as well as the cecum, which were stripped of underlying smooth muscle and mounted in Ussing chambers. Although the trend was toward increased permeability in the distal colon of Hvem Ϫ / Ϫ mice, the diff erence was not signifi cant when compared with WT tissues. However, permeability in the distal colon of both WT and Hvem Ϫ / Ϫ mice was signifi cantly lower than that observed in infl amed tissues isolated from WT mice with colitis that had been induced by dextran sodium sulfate (DSS) (Fig. S2 B) . Similar to the results from the distal large intestine, permeability in the proximal colon and cecum of WT and Hvem Ϫ / Ϫ animals was essentially equivalent (not depicted). Therefore, epithelial permeability is not compromised under noninfl ammatory conditions in the absence of HVEM expression. Colitis induced by DSS represents a well-established epithelial injury model of intestinal infl ammation. Hvem Ϫ / Ϫ mice also displayed no increase in susceptibility to DSS-induced colitis when compared with WT mice (Fig. S3, A and B ).
Effects of HVEM ligand expression by T cells
An appealing hypothesis for explaining the accelerated colitis in Hvem Ϫ / Ϫ Rag Ϫ / Ϫ recipients is that enhanced disease is caused by the absence of an interaction between HVEM expressed by a cell type in the Rag Ϫ / Ϫ recipients with an HVEM binding partner expressed by the donor T cells. Recent publications have suggested that expression of LIGHT by T cells is able to regulate innate immune responses by interacting with the HVEM receptor ( 36, 38 -41 ) . Therefore, the absence of interactions between T cell -derived LIGHT and HVEM on host cells might lead to a dysregulated innate immune response in also reduced (mean fl uorescence intensity = 7,456 for LPL vs. mean fl uorescence intensity = 26,183 for MLNs). Surprisingly, although BTLA is an inhibitory receptor, Btla Ϫ / Ϫ T cells transferred into Rag Ϫ / Ϫ animals induced colitis similar to WT donors when weight loss was measured ( Fig. 6 C ) . Histological analysis performed 2 wk after transfer revealed higher average scores for recipients transferred with Btla Ϫ / Ϫ T cells, but there was no diff erence at 5 wk ( Fig. 6 D ) .
Reduced number of BTLA-defi cient T cells in Rag ؊ / ؊ recipients
It has been recently shown that BTLA plays a role in the survival of T cells activated in a mouse GVHD model ( 32 ) . In light of our fi nding that Rag Ϫ / Ϫ recipients of BTLA-defi cient T cells did not develop accelerated colitis, we hypothesized that BTLA-defi cient T cells transferred into Rag Ϫ / Ϫ recipients might have a survival defect, leading to a reduced number of eff ector T cells that ultimately might aff ect the onset of colitis. To address this possibility, we performed cotransfers of equal numbers of WT CD45.1 + congenic and Btla Ϫ / Ϫ CD45.2 + CD4 + CD45RB high T cells into Rag Ϫ / Ϫ recipients. Btla Ϫ / Ϫ T cells did not accumulate as much as WT cells. The percentages ( Fig. 7 A ) and absolute numbers ( Fig. 7 B ) of CD45.1 + CD4 + TCR-␤ + cells in the spleens, MLNs, LPLs, and intestinal epithelial lymphocytes (IELs) were considerably higher than those for Btla Ϫ / Ϫ (CD45.1 Ϫ ) T cells 2 wk after transfer. Although the Btla Ϫ / Ϫ T cells did not accumulate as much as WT donors, the BTLA-defi cient T cells in Rag Ϫ / Ϫ mice were capable of secreting proinfl ammatory cytokines to a similar extent ( Fig. 7 C ) . Based on these fi ndings, we hypothesize that transfer of Btla Ϫ / Ϫ T cells did not recapitulate the results in Hvem Ϫ / Ϫ Rag Ϫ / Ϫ recipients in part because the lower numbers of eff ector T cells prevented disease acceleration.
Signaling through BTLA prevented colitis acceleration
To further explore the role of the BTLA inhibitory receptor, we evaluated colitis development in recipient Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice treated with an anti-BTLA mAb (clone 6F7). When added to T cell -APC co-cultures stimulated with an anti-CD3 antibody, the 6F7 antibody attenuated T cell responses. The expression of CD25 and the production of IL-2 by anti-BTLA -treated T cells were reduced compared with the IgG-treated control (Fig. S4 , available at http://www .jem.org/cgi/content/full/jem.20071160/DC1). Importantly, the inhibitory eff ect on immune responses mediated by the 6F7 antibody was specifi c to BTLA-expressing T cells, as the activation and proliferation of Btla Ϫ / Ϫ T cells was essentially equivalent in cultures treated with the 6F7 mAb or an irrelevant IgG control (Fig. S4 B) . The anti-BTLA mAb reduced IL-2 and CD25 induction even when Hvem Ϫ / Ϫ T cells and APCs were co-cultured ( Fig. S4 D) , indicating that the mAb acts directly by engaging BTLA, as opposed to blocking interactions with HVEM. These results indicate that the anti-BTLA mAb 6F7 has agonistic activity that stimulates BTLA-mediated inhibitory signals leading to decreased T cell -immune responses in vitro.
Therefore, rapid colitis induction in the absence of HVEM expression is dominant over the decreased infl ammation observed when Light Ϫ / Ϫ T cells were transferred.
The inhibitory HVEM ligand BTLA is expressed by activated T cells, and therefore interactions between Rag Ϫ / Ϫ host HVEM and T cell BTLA could alter the acceleration of colitis. To test this, we evaluated BTLA expression by naive CD4 + T cells and by CD4 + T cells after transfer. Consistent with previous reports ( 42 ) , we detected BTLA expression on naive and activated CD4 + T lymphocytes. In vitro TCR stimulation enhanced BTLA expression on CD4 + T cells, with the highest level of BTLA observed 2 -3 d after stimulation ( Fig. 6 A ) . Likewise, we found BTLA expression on CD4 + T cells isolated from the spleens, MLNs, and LPLs of transferred Rag Ϫ / Ϫ recipients ( Fig. 6 B ) . Although BTLA expression on LPLs was slightly lower than that observed on T cells from the spleens or MLNs, this was likely a consequence of the reduced surface protein expression caused by the collagenase digestion during LPL isolation. Consistent with this, the amount of CD4 was all the transferred animals presented with severe intestinal infl ammation and similar histological average scores ( Fig. 8 D ) . These results demonstrate that the anti-BTLA mAb prevents colitis acceleration when the donor T cells express BTLA. Therefore, we conclude that BTLA signaling on T cells mediated by HVEM expressed by an irradiation-resistant cell is crucial to prevent colitis acceleration.
Accelerated colitis in Btla ؊ / ؊ Rag ؊ / ؊ recipients Although the eff ect of the agonistic anti-BTLA mAb required BTLA expression by T cells, the experiments presented above prove only that T cell expression of BTLA is necessary, but not suffi cient, and therefore it remained possible that BTLA expression by host cells in the Rag Ϫ / Ϫ mice may also be required for preventing colitis acceleration. To investigate this possibility, we used Btla Ϫ / Ϫ Rag Ϫ / Ϫ animals as recipients of WT CD4 + CD45RB high T cells. The transfer of T cells into Btla Ϫ / Ϫ Rag Ϫ / Ϫ recipients led to faster weight loss ( Fig. 9 A ) . Furthermore, histological analysis performed 2 wk after the transfer on samples isolated from the large intestine revealed a more severe intestinal infl ammation in Btla Ϫ / Ϫ Rag Ϫ / Ϫ mice ( Fig. 9 B ) . To determine if disease acceleration in Btla Ϫ / Ϫ Rag Ϫ / Ϫ mice was comparable to that observed in HVEM-defi cient
We found that the anti-BTLA mAb also has agonistic activity in vivo. Injection of the anti-BTLA mAb every 3 d beginning at the time of T cell transfer greatly delayed weight loss and disease progression ( Fig. 8 A ) . Furthermore, Hvem Ϫ / Ϫ Rag Ϫ / Ϫ recipients treated with the anti-BTLA mAb had lower average histological scores ( Fig. 8 B ) . Collectively, these results demonstrate that BTLA engagement was required to prevent colitis acceleration, and they suggest that the rapid development of disease in Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice is likely to be caused by the absence of BTLA signaling.
To evaluate if the anti-BTLA mAb prevents colitis by acting on donor T cells, we transferred Btla Ϫ / Ϫ CD4 + CD45RB high T cells into Hvem Ϫ / Ϫ Rag Ϫ / Ϫ recipients that were then treated with the anti-BTLA mAb. Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice transferred with Btla Ϫ / Ϫ T cells showed faster weight loss regardless of treatment with the anti-BTLA mAb ( Fig. 8 C ) . In addition, Hvem Ϫ / Ϫ mice do not have a dramatic phenotype, however, which might refl ect the balance between the activating and inhibitory signals mediated by HVEM.
In this report, we analyzed the role of HVEM in intestinal infl ammation induced by the transfer of naive CD4 + T cells into Rag Ϫ / Ϫ mice. This experimental system is well suited to the analysis of complex networks of receptor -ligand interactions because disease development is synchronous and the genotypes of the donor T cells and the immune-defi cient host can be independently varied. The most striking fi nding in the work presented here was the dramatic acceleration of colitis observed in Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice transferred with WT CD4 + CD45RB high T cells. Clinical signs correlated with an extremely fast weight loss and elevated histological scores in the colon within 2 wk after T cell transfer. Colitis acceleration in Hvem Ϫ / Ϫ Rag Ϫ / Ϫ recipient mice was characterized by a rapid accumulation of activated T cells producing Th1 cytokines and IL-17 in the large intestine of these recipients. This suggests that colitis acceleration is probably induced by an exacerbated proinfl ammatory response mediated by CD4 + T cells in the large intestine.
Because of the surprising acceleration of disease in Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice, we performed experiments to identify the critical cell type(s) that must express HVEM. Although APCs were considered the most promising candidate, we could fi nd little evidence for a global alteration in APC function in Hvem Ϫ / Ϫ mice, although T cells cultured in vitro with Hvem Ϫ / Ϫ MLN DCs and a soluble anti-CD3 mAb did exhibit a slightly enhanced proliferative response. Surprisingly, transfer experiments using BM chimeric mice revealed that HVEM expression on a radioresistant cell population in the Rag Ϫ / Ϫ animals is most critical for preventing colitis acceleration. Moreover, we found that mouse IECs expressed high levels of HVEM. IECs are a main point of contact for enteric antigens, and they play a direct role in regulating T cell responses to these antigens ( 44 ) . It has been recently shown that IECs may contribute to the maintenance of T cell tolerance in the gut by preventing inappropriate activation of CD4 + T cells ( 45, 46 ) , and they express PD-L1, the ligand for the inhibitory receptor programmed cell death 1 ( 46 ) . Nevertheless, although epithelial cell expression of HVEM is intriguing, IEC permeability was not altered in Hvem Ϫ / Ϫ mice, and these mice were not more susceptible to DSS colitis. Therefore, the absence of HVEM does not alter IEC physiological function in the absence of T cell -induced infl ammation, and it remains to be proven that HVEM expression by IECs is required to prevent colitis acceleration. A radioresistant, tissue-specifi c APC expressing CD70, and required for the proliferation of mucosal T cells after oral infection, was recently identifi ed ( 47 ) , and therefore these cells or some other radioresistant HVEM-expressing cell type could be most responsible for preventing accelerated colitis. Conditional ablation of HVEM expression in diff erent cell types in Rag Ϫ / Ϫ mice with a fl oxed Hvem allele ultimately will be required to identify the cell type(s) that must express this protein to prevent disease acceleration.
hosts, WT CD4 + CD45RB high were simultaneously transferred into Btla Ϫ / Ϫ Rag Ϫ / Ϫ or Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice. In the two groups of recipients, colitis development was essentially equivalent. Although the trend was toward slightly less weight loss and less severe histological scores in Btla Ϫ / Ϫ Rag Ϫ / Ϫ mice than in Hvem Ϫ / Ϫ Rag Ϫ / Ϫ mice, the diff erence did not reach statistical signifi cance ( Fig. 9, C and D ) . Similar results were obtained when Btla Ϫ / Ϫ Rag Ϫ / Ϫ recipients were transferred with Btla Ϫ / Ϫ CD4 + CD45RB high , a situation where BTLA was absent in both donor and host cells ( Fig. 9, C and D ) . Collectively, these results demonstrate that BTLA expression by Rag Ϫ / Ϫ host cells also prevents accelerated colitis in the T cell transfer model.
DISCUSSION
HVEM is a unique TNF family receptor because it has the ability both to transmit positive signals and to induce negative signals. Subsets of T cells constitutively express HVEM, and therefore it is perhaps not surprising that many of the experiments analyzing the role of HVEM have focused on T lymphocytes. HVEM expressed by T cells is a co-stimulatory receptor for LIGHT-mediated T cell activation ( 8, 9, 18, 22, 25 ) . Furthermore, recent reports demonstrated that HVEM also engages BTLA and inhibits T cell proliferation ( 25, 26, 43 ) . ferred mice were monitored regularly for signs of disease, including weight loss, hunched over appearance, piloerection of the coat, and diarrhea. For cotransfer experiments, CD4 + CD45RB high T cells were isolated from congenic CD45.1 + and CD45.2 + Btla Ϫ / Ϫ mice, mixed in equal numbers and injected i.v. into Rag Ϫ / Ϫ recipients.
Preparation of IELs and LPLs. Mucosal lymphocytes were isolated and prepared as described previously ( 34 ) . In brief, the large intestine was removed and placed in chilled HBSS media containing 5% FCS. The intestines were carefully cleaned from their mesenteries and fl ushed of fecal content. Intestines were opened longitudinally and cut into 1-cm pieces. The intestinal tissue was transferred to 250-ml Erlenmeyer fl asks containing 25 ml of preheated HBSS supplemented with 2% FBS and 1 mM DTT (Sigma-Aldrich) and shaken at 200 rpm for 40 min at 37 ° C. The tissue suspensions were passed through a stainless steal sieve into 50-ml conical tubes, and the cells were pelleted by centrifugation at 1,200 rpm for 10 min at 4 ° C. The cell pellets were resuspended in complete HBSS, layered over a discontinuous 40/70% Percoll (GE Healthcare) gradient, and centrifuged at 2,000 rpm for 30 min. Cells from the 40/70% interface were collected, washed, and resuspended in complete RPMI media (Invitrogen). These purifi ed cells constituted the IEL population. To isolate LPLs, the remaining intestinal tissue in the stainless steal sieve was minced and transferred to conical tubes. The minced pieces were resuspended in 20 ml of complete RPMI containing 1 mg/ml of type IV collagenase (Sigma-Aldrich) and shaken at 200 rpm for 40 min at 37 ° C. The tissue suspension was collected and passed through a 70-μ m cell strainer, and then the cells were pelleted by centrifugation at 1,200 rpm. The cells were then resuspended and layered onto a 40/70% Percoll gradient, centrifuged, and processed as described above for the IEL preparation.
Histology. At various time points after cell transfer, animals were killed for histological analysis. Tissue samples of 3 -5 mm obtained from distal and proximal portions of the large intestine were fi xed in 4% formalin. Fixed tissues were later embedded in paraffi n and 3-μ m sections were prepared and stained with H & E. To evaluate the severity of the infl ammation, samples were coded and scored by a pathologist in a blinded fashion using a previously described scoring system ( 34 ) . Scores from the two parts of the intestine were averaged to represent the severity of disease. Higher scores (maximum 14) indicate greater pathology. Categories scored are the following: degree of infl ammatory cell infi ltrate in the lamina propria, goblet cell depletion, epithelial cell reactive atypia/hyperplasia, number of IELs in epithelial crypts, and number of infl ammatory foci.
Flow cytometry analysis. Spleens and MLNs were removed and then mashed through a 70-μ m cell strainer, and red blood cells in the cell suspension were removed using a lysing buff er (Sigma-Aldrich). IELs and LPLs were isolated as described above. Before staining, cells were washed and resuspended in staining buff er containing 1 × PBS, 2% BSA, 10 mM EDTA, and 0.01 NaN 3 . To block nonspecifi c staining, anti-CD16/32 antibody was added. Antibodies for cell surface markers were added, and cells were incubated for 20 min on ice. After staining, the cells were washed twice with staining buff er, analyzed the same day or fi xed in PBS containing 1% paraformaldehyde and 0.01 NaN 3 , and analyzed later in a FACSCalibur (BD Biosciences).
Detection of cytokines by ELISA. 2 wk after the transfer of CD4 + CD45RB high T cells, LPLs were isolated from the recipients and 10 6 cells were cultured in RPMI complete medium in the presence of PMA and ionomycin for 48 h. The amounts of IFN-␥ , IL-4, TNF, and IL-2 in the culture supernatants were quantifi ed by ELISA. Antibodies and recombinant cytokine standards were purchased from BD Biosciences.
RNA isolation and real-time PCR. 2 wk after the transfer of CD4 + CD45RB high T cells, 1.5 cm from the large intestines of the recipients was removed and resuspended in TRIZol (Invitrogen). The samples were other mechanisms prevent gut infl ammation. Moreover, the counterbalancing eff ects of HVEM expression by diff erent cell types, and the dual engagement of proinfl ammatory LIGHT and antiinfl ammatory BTLA by HVEM, may explain the absence of spontaneous colitis in Hvem Ϫ / Ϫ mice. Our fi ndings therefore depended critically on the power of the T cell transfer model of colitis in analyzing cell -cell interactions and the interplay of the innate adaptive immune systems, as we could separate the proinfl ammatory and antiinfl ammatory eff ects of HVEM expression by comparing Hvem Ϫ / Ϫ T cell donors and Hvem Ϫ / Ϫ Rag Ϫ / Ϫ recipients to their WT counterparts. Although the majority of studies on HVEM have addressed the participation of this molecule when expressed by T cells or APCs, our studies demonstrate the unexpected and important role that this molecule plays to prevent infl ammation when expressed by irradiation-resistant nonlymphoid cells. The expression of HVEM and BTLA on both innate and adaptive cells, along with the fi ndings presented here, suggest that this ligand -receptor system could play diverse roles in immunity and infl ammation in both the innate and adaptive immune systems that have yet to be fully elucidated.
MATERIALS AND METHODS
Mice. C57BL/6, Rag Ϫ / Ϫ (C57BL/6 background), and C57BL/6-SJL CD45.1 congenic mice were purchased from The Jackson Laboratory and maintained in our facility. Btla Ϫ / Ϫ ( 28 ), Light Ϫ / Ϫ ( 37 ), and Hvem Ϫ / Ϫ mice ( 26 ) have been described previously. All gene-defi cient mice were backcrossed for at least six generations onto the C57BL/6 background. Hvem Ϫ / Ϫ or Btla Ϫ / Ϫ mice were crossed to Rag Ϫ / Ϫ mice to generate Hvem Ϫ / Ϫ Rag Ϫ / Ϫ and Btla Ϫ / Ϫ Rag Ϫ / Ϫ recipient animals, respectively. Mice were maintained at the La Jolla Institute for Allergy and Immunology under specifi c pathogen-free conditions, and sentinels from the mouse colony tested negative by PCR detection of Helicobacter spp . and Citrobacter rodentium . Mice were used at 7 -12 wk of age. Animal care and experimentation were consistent with the National Institutes of Health guidelines and were approved by the Institutional Animal Care and Use Committee at the La Jolla Institute for Allergy and Immunology.
Antibodies and reagents. The following mouse antibodies were purchased from BD Biosciences as conjugated to FITC, PE, PE-Cy5, PerCP-Cy5.5, or allophycocyanin: CD4 (L3T4), CD45RB (16A), CD45.2 (104), TCR ␤ chain (H57-597), and rat anti -hamster IgG (cocktail). A PE-conjugated and purified anti -mouse BTLA mAb (6F7) were purchased from eBioscience and Bio Express, Inc., respectively. Antimouse HVEM antibody ( 26 ) was provided by Y.X. Fu (University of Chicago, Chicago, IL). Anti -mouse CD16/32 used for Fc receptor blocking was purifi ed in our laboratory. Purifi ed mouse IgG1 was purchased from Millipore.
CD4 + CD45RB high T cell isolation and transfers.
Spleens were removed from the donor mice (C57BL/6, Light Ϫ / Ϫ , Hvem Ϫ / Ϫ , Btla Ϫ / Ϫ , or B6-SJL CD45 congenic) and teased into cell-single suspensions in HBSS media (Invitrogen). Cell suspensions were fi ltered through a 70-μ m cell strainer (Thermo Fisher Scientifi c), and then CD4 + cells were enriched by positive selection using anti-CD4 (L3T4) microbeads according to the manufacturer ' s protocol (Miltenyi Biotec). The CD4 + -enriched cells were washed twice and stained with PE-Cy5 -conjugated anti-CD4 and PE-conjugated anti-CD45RB antibodies. After staining, the cells were washed, and the CD4 + CD45RB high T cell population was sorted by fl ow cytometry using a FACS-DIVA cell sorter (Becton Dickinson). Purifi ed CD4 + CD45RB high naive T cells were washed twice and resuspended in PBS, and 5 × 10 5 cells in 200 μ l of PBS were injected i.v. into the diff erent recipient mice. Trans-Generation of BM chimeras. Rag Ϫ / Ϫ or Hvem Ϫ / Ϫ Rag Ϫ / Ϫ hosts were lethally irradiated with 11 Gy that were applied in two irradiations of 5.5 Gy separated by a 3-h interval. After irradiation, Hvem Ϫ / Ϫ Rag Ϫ / Ϫ hosts were transplanted with 5 × 10 6 total BM cells isolated from Rag Ϫ / Ϫ mice to generate Rag Ϫ / Ϫ → Hvem Ϫ / Ϫ Rag Ϫ / Ϫ chimeric animals. Reciprocal Hvem Ϫ / Ϫ Rag Ϫ / Ϫ → Rag Ϫ / Ϫ chimeras were generated by transplanting Hvem Ϫ / Ϫ Rag Ϫ / Ϫ BM cells into irradiated Rag Ϫ / Ϫ hosts. After transplant, mice were maintained under antibiotic treatment for 4 wk and an additional 6 wk without antibiotic before transfer of the CD4 + CD45RB high T cells.
Statistics. Diff erences between groups were evaluated for statistical significance by the two-tailed unpaired Student ' s t test, except for histological scoring that was evaluated using Wilcoxon ' s two-group test. Results are expressed as mean ± SD. p-values of < 0.05 were considered signifi cant.
Online supplemental material. Fig. S1 (A and B) shows, respectively, the phenotype of freshly isolated or LPS-stimulated CD11c + cells isolated from the MLNs of WT or Hvem Ϫ / Ϫ mice. Fig. S1 C shows proliferation assessed by CFSE dilution of CD4 + CD25 Ϫ T cells cultured with WT or Hvem Ϫ / Ϫ CD11c + and an anti-CD3 mAb. Fig. S2 A shows HVEM expression on purifi ed primary colonic epithelial cells. Fig. S2 B shows the results from intestinal permeability experiments performed on distal colons isolated from untreated WT and Hvem Ϫ / Ϫ mice or WT animals treated with 4% DSS. Fig.  S3 (A and B) shows, respectively, weight loss curves and histological scores of WT and Hvem Ϫ / Ϫ mice treated with 2.5% DSS. Fig. S4 (A -D) shows the eff ect of an anti-BTLA mAb (6F7) on T cell activation, in particular CD25 expression and IL-2 production. The online supplemental material is available at http://www.jem.org/cgi/content/full/jem.20071160/DC1.
